Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France
- 1 January 2005
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 37 (6-7), 482-487
- https://doi.org/10.1080/00365540510035328
Abstract
The objective of the study was to describe the underlying causes of death of HIV-infected patients in the HAART era and to focus on those related to opportunistic infection (OI), in a national multicentre study ('Mortalité 2000'). A total of 964 deaths were recorded and 924 cases were available for analysis. Underlying cause of death were AIDS-related (47%), viral hepatitis (11%), non-AIDS cancers (11%), cardiovascular diseases (7%) and others (11%). Among patients who died of AIDS events, 262 (27%) died of at least one OI. OIs reported at the time of death were Cytomegalovirus infection 67 times, Pneumocystis jiroveci pneumonia 56, disseminated Mycobacterium avium intracellulare infection 53 and cerebral toxoplasmosis 48. Compared to patients who died of other causes, patients who died of OIs were younger and more likely to be infected through heterosexual contact, in poor socioeconomic conditions, migrants, more recently diagnosed for HIV infection, and naive of antiretroviral therapy and OI prophylaxis. OIs are still a major cause of death in HIV-infected patient in the HAART era, especially among patients recently diagnosed for HIV infection and who do not have access to care, as well as in long term infected patients where prophylaxis should be revisited.Keywords
This publication has 12 references indexed in Scilit:
- Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDSInternational Journal of Epidemiology, 2004
- The changing face of the HIV epidemic in western Europe: what are the implications for public health policies?The Lancet, 2004
- Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)The Journal of Infectious Diseases, 2002
- Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapyAmerican Journal Of Medicine, 2002
- Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA studyAIDS, 2002
- Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999HIV Medicine, 2002
- Socioeconomic Status and Survival of Persons with AIDS before and after the Introduction of Highly Active Antiretroviral TherapyEpidemiology, 2000
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Survival after introduction of HAART in people with known duration of HIV-1 infectionThe Lancet, 2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998